6. Invacare ( IVC) designs, manufactures and distributes a range of health care products for the non-acute care environment, including the home health care and extended care markets. The stock has gained 19% in the past one year. The company will report its first quarter 2011 results on Apr. 28. Total revenue is projected to increase marginally to $404.5 million from $402.2 million in the year-ago quarter. However, net income is forecasted to more than double to $6.8 million or 25 cents per share from $3.1 million or 9 cents per share reported in the first quarter of 2010. Invicare recently paid a cash dividend of $0.0125 per share on its common shares and $0.011364 per share on its Class B common shares. Also, the company revealed that for 2011 it expects organic sales growth of 2%-4%, adjusted EPS of $2.05-$2.15 and adjusted EBITDA of $145-$155 million. Analysts at Zacks Investment Research reiterated a neutral rating on the shares. Of the five analysts covering the stock, 20% recommend it a buy, while the remaining rate a hold. There are no sell ratings on the stock. On average, analysts expect an upside of 6.4% to $34.5 in value from current levels.